Stone et al. has demonstrated an increased risk of deep vein thrombosis with tumor-derived IL-6 in a mouse model of ovarian cancer via the induction of hepatic thrombopoietin, promoting thrombus formation [8]. Here, THPO is linked to deep vein thrombosis.